UMediC Group Berhad - Asset Resilience Ratio
UMediC Group Berhad (0256) has an Asset Resilience Ratio of 1.48% as of October 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See UMediC Group Berhad current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how UMediC Group Berhad's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is UMediC Group Berhad's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down UMediC Group Berhad's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read debt load of UMediC Group Berhad for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM0.00 | 0% |
| Short-term Investments | RM1.41 Million | 1.48% |
| Total Liquid Assets | RM1.41 Million | 1.48% |
Asset Resilience Insights
- Limited Liquidity: UMediC Group Berhad maintains only 1.48% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
UMediC Group Berhad Industry Peers by Asset Resilience Ratio
Compare UMediC Group Berhad's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.29% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
Annual Asset Resilience Ratio for UMediC Group Berhad (2022–2025)
The table below shows the annual Asset Resilience Ratio data for UMediC Group Berhad.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-07-31 | 5.43% | RM4.95 Million ≈ $1.24 Million |
RM91.22 Million ≈ $22.90 Million |
-5.79pp |
| 2024-07-31 | 11.22% | RM9.28 Million ≈ $2.33 Million |
RM82.71 Million ≈ $20.77 Million |
-4.98pp |
| 2023-07-31 | 16.20% | RM11.87 Million ≈ $2.98 Million |
RM73.29 Million ≈ $18.40 Million |
-14.29pp |
| 2022-07-31 | 30.49% | RM21.01 Million ≈ $5.27 Million |
RM68.89 Million ≈ $17.30 Million |
-- |
About UMediC Group Berhad
UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales s… Read more